Pfizer Inc. Shares PFE,
fell 2.1% in trading operations on Tuesday morning, even after the drug maker provided an optimistic earnings outlook for that year. Speaking at the JP Morgan Health Care conference, CEO Albert Bourla said the company projects a 2021 adjusted earnings per share of $ 3.00 to $ 3.10, which is above the current FactSet consensus $ 2.96 EPS. The company revealed in a document submitted to the Securities and Exchange Commission that financial guidance is subject to a number of assumptions, including current expectations regarding the impact of the procurement and supply of COVID-19 pandemic vaccines and COVID-19, which remain dynamic. “Pfizer, with partner BioNTech SE BNTX,
you have supplied a COVID-19 vaccine since it was authorized for emergency use by the Food and Drug Administration. The number of Americans who have received vaccines against COVID-19 so far has been well below expectations. Pfizer shares have gained 6.1% in the last three months, while SFDR Health Care Select Sector ETF XLV,
has advanced 7.1% and the S&P 500 SPX,
has attacked 7.6%.